Biobanking Market to Reach $18,535.1 Million by 2035

What is Biobanking and Why Does It Matter?

 Biobanking refers to the systematic collection, processing, storage, and management of biological samples such as blood, tissues, DNA, RNA, and cell lines, along with associated clinical and omics data. These repositories serve as critical infrastructure supporting biomedical research, drug discovery, and the advancement of personalized medicine.

As healthcare increasingly shifts toward precision medicine and multi-omics research, biobanks play a vital role in enabling researchers to access high-quality, well-annotated biospecimens. Modern biobanking is evolving from traditional storage systems to automated, high-density storage solutions integrated with digital platforms that enhance accessibility, traceability, and research efficiency.

According to BIS Research, the global biobanking market was valued at $7,366.2 million in 2024 and is projected to reach $18,535.1 million by 2035, growing at a CAGR of 8.87% during the forecast period 2025-2035, driven by increasing investments in genomics, clinical trials, and data-driven healthcare innovation.

Download the complete TOC and Request Sample Report

What’s Driving Growth in the Biobanking Market?

 Key Drivers:

•    Growing investments in precision medicine and personalized therapeutics
•    Rising demand for high-quality biospecimens in complex clinical trials
•    Expansion of genomic and population health research programs
•    Adoption of automation and high-density sample storage technologies
•    Integration of AI and digital platforms for data management and sample traceability

What Are the Challenges in the Biobanking Market?

 Key Challenges:
•    High capital and operational costs associated with advanced storage infrastructure
•    Energy-intensive operations and maintenance of cold-chain systems
•    Data governance, consent management, and regulatory compliance complexities
•    Risk of sample degradation due to equipment failure or cryogenic disruptions
•    Limited standardization across emerging markets and smaller biobanks

What is the Recent Development in Biobanking Market?

•    March 2025: Galatea Bio secured $25 million in Series A funding to build a global multi-ancestry biobank, aiming to improve representation in genomic datasets.
•    October 2025: Cryoport, Inc. launched a 55,000-square-foot Global Supply Chain Center in France to enhance temperature-controlled logistics for advanced therapies.
•    February 2025: Cryoport introduced the Cryoport Express Cryogenic HV3 Shipping System to improve protection and compliance for sensitive biologics.
•    January 2025: Azenta, Inc. partnered with UK Biocentre to expand large-scale sample storage capacity using advanced BioArc Ultra systems.

Market Segmentation: Where Are Growth Opportunities?

 By Region
 • North America
 o U.S.
 o Canada
 • Europe
 o U.K.
 o Germany
 o France
 o Italy
 o Spain
 o Rest-of-Europe
 • Asia-Pacific
 o China
 o Japan
 o Australia
 o India
 o Rest-of-Asia-Pacific
 • Rest-of-the-World

Analyst Perspective: What’s Next for Biobanking?

 According to Principal Analyst at BIS Research:
 “The biobanking market is undergoing a significant transformation from conventional storage systems to integrated, data-driven infrastructures that support precision medicine and multi-omics research. Europe leads due to strong governance frameworks and coordinated biobank networks, while North America continues to advance in automation and digital traceability. Emerging opportunities lie in virtual biobanking, interoperable platforms, and AI-driven analytics, although cost pressures and operational risks remain key challenges.”

FAQs About the Biobanking Market

 What is the expected growth outlook?
 The biobanking market is expected to grow at a CAGR of 8.87% from 2025 to 2035, reaching $18,535.1 million by 2035, driven by advancements in precision medicine and genomics.

Who are the key leaders in this market?
 Key players include Thermo Fisher Scientific, BD, QIAGEN, Danaher (Cytiva), Azenta, PHC Corporation, Eppendorf, Cryoport, BioLife Solutions, Avantor, Greiner AG, Hamilton Company, and Tecan Trading AG.

Which trends are shaping the market?
 Automation, digital data integration, virtual biobanking, and AI-enabled analytics are key trends, alongside growing demand for standardized, high-quality biospecimens.

Want to Make Data-Backed Moves in the Biobanking Market?
 BIS Research provides expert-driven insights, granular segmentation, and strategic advisory across healthcare, life sciences, and emerging technology domains.

Request a sample report
Book a Preview
Download the complete TOC